Hussman Strategic Advisors’s Qiagen QGEN Stock Holding History

Hussman Strategic Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-84,000	Closed	-$3.36M	–	306
2026 Q1	$3.36M	Buy	+84,000	New	+$3.98M	0.73%	21
2017 Q4	–	Sell	-23,576	Closed	-$788K	–	208
2017 Q3	$788K	Hold	23,576	–	–	0.19%	124
2017 Q2	$838K	Sell	23,576 -91,665	-80%	-$3.1M	0.19%	114
2017 Q1	$3.54M	Buy	+115,241	New	+$3.55M	0.78%	60

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hussman Strategic Advisors's QGEN Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 84,000 shares — an estimated $3.36M sold.

Hussman Strategic Advisors first reported a position in QGEN in Q1 2017 and held it in 4 quarters. The position peaked at $3.54M in Q1 2017. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Hussman Strategic Advisors reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Hussman Strategic Advisors sold 84,000 Qiagen shares in Q2 2026, an estimated $3.36M.
Hussman Strategic Advisors first reported a position in Qiagen in Q1 2017 and held it in 4 quarters.
Hussman Strategic Advisors's Qiagen position peaked at $3.54M in Q1 2017.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.